1. He, Zhixian, Wang, Feiran, Zhang, Wei, Ding, Jinhua, Ni, Sujie. . Comprehensive and integrative analysis identifies COX7A1 as a critical methylation-driven gene in breast invasive carcinoma. In Annals of translational medicine, 7, 682. doi:10.21037/atm.2019.11.97. https://pubmed.ncbi.nlm.nih.gov/31930083/
2. Feng, Yetong, Xu, Jiayi, Shi, Mengjiao, Du, Wenjing, Liu, Pengfei. 2022. COX7A1 enhances the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via regulating mitochondrial metabolism. In Cell death & disease, 13, 988. doi:10.1038/s41419-022-05430-3. https://pubmed.ncbi.nlm.nih.gov/36418320/
3. Rönn, T, Poulsen, P, Hansson, O, Vaag, A, Ling, C. 2008. Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. In Diabetologia, 51, 1159-68. doi:10.1007/s00125-008-1018-8. https://pubmed.ncbi.nlm.nih.gov/18488190/
4. Wang, Si-Yu, Yang, Xian-Qi, Wang, Yu-Xin, Yuan, Zhi-Ping, Yuan, Shu-Qiang. 2024. Overexpression of COX7A1 Promotes the Resistance of Gastric Cancer to Oxaliplatin and Weakens the Efficacy of Immunotherapy. In Laboratory investigation; a journal of technical methods and pathology, 104, 102090. doi:10.1016/j.labinv.2024.102090. https://pubmed.ncbi.nlm.nih.gov/38830579/
5. Zhao, Lei, Chen, Xin, Feng, Yetong, Hu, Lifu, Liu, Pengfei. 2019. COX7A1 suppresses the viability of human non-small cell lung cancer cells via regulating autophagy. In Cancer medicine, 8, 7762-7773. doi:10.1002/cam4.2659. https://pubmed.ncbi.nlm.nih.gov/31663688/